SCHEMBL3087341

SCHEMBL3087341

CCOc1ccc2c(c1)CNCCn1c-2cc2ccc(C(=O)O)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
CSNK2A3 Q8NEV1 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
RPS6KA2 Q15349 5/20 0.37
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
SSTR5 P35346 3/20 0.36
RPS6KA3 P51812 3/20 0.36
PLA2G4B P0C869 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MAPT P10636 1/20 0.35
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
TP53 P04637 1/20 0.35
PKM P14618 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3095189 0.86 GPR84 (0.40) RPS6KA2RPS6KA3L3MBTL1RXRARXRB
SCHEMBL3079143 0.85 GPR84 (0.42) CSNK2A2CSNK2A1RPS6KA2RPS6KA3
SCHEMBL3087467 0.82 RPS6KA3 (0.39) HTR2AHTR2CRPS6KA2RPS6KA3MAPKAPK2
SCHEMBL3092044 0.80 RPS6KA2 (0.43) HTR2AHTR2CRPS6KA2RPS6KA3MAPKAPK2
SCHEMBL3083810 0.73 RPS6KA3 (0.41) RPS6KA2RPS6KA3MAPKAPK2
SCHEMBL3086678 0.73 RPS6KA3 (0.43) RPS6KA2RPS6KA3MAPKAPK2
SCHEMBL3084506 0.73 KDM4E (0.44) HTR2AHTR2CRPS6KA2RPS6KA3L3MBTL1
SCHEMBL3092096 0.73 RPS6KA2 (0.45) HTR2AHTR2CRPS6KA2RPS6KA3
SCHEMBL3087336 0.72 RPS6KA2 (0.42) RPS6KA2RPS6KA3MAPKAPK2
SCHEMBL3088133 0.71 RPS6KA3 (0.54) HTR2AHTR2CRPS6KA2RPS6KA3MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795247-B2 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-09-14 US disclosed
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents ISTITUTO DI RICHERCHEDI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IRMB) (IT) 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100262-A1 Tetracyclic indole derivatives as antiviral agents IDO1, ZC3HAV1, IDO2 CSNK2A2 193/4885CSNK2B 319/4885CSNK2A1 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.